Boardroom Alpha
Boardroom Alpha
RVTY · Current Report (Form 8-K) · Filed May 1, 2026

Revvity Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 1, 2026
Period
Apr 28, 2026
Ticker
RVTY
Accession
0001193125-26-201401
Boardroom Alpha · Filing insights

Shareholders approved By-law amendment enabling 25% stockholders to call a special meeting.

About Revvity Inc
Market cap
$11.2B
1Y TSR
+2.8%
3Y TSR
−5.5%
Board grade
C
Sector
Healthcare
CEO
Prahlad R Singh
Last annual meeting: Apr 28, 2026 · View full Revvity Inc profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 28, 2026

 

 

Revvity, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Massachusetts   001-05075   04-2052042

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

77 4th Avenue, Waltham, Massachusetts   02451
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (781) 663-6900

Not applicable.

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol

 

Name of exchange

on which registered

Common stock, $1 par value per share   RVTY   The New York Stock Exchange
1.875% Notes due 2026   RVTY26   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.03

Amendments to Articles of Organization or Bylaws; Change in Fiscal Year

At the annual meeting of shareholders of Revvity, Inc. (the “Company”) held on April 28, 2026, the shareholders voted on and approved a proposal to amend the Company’s Amended and Restated By-laws (prior to such amendment and restatement, the “Prior By-laws”) to allow shareholders owning 25% of the Company’s stock to call a special meeting of shareholders (as amended and restated, the “Amended and Restated By-laws”) effective as of April 28, 2026. A copy of the Amended and Restated By-laws, in redline form to show the amendments made by the Company to the Prior By-laws, is attached hereto as Exhibit 3.1 and incorporated herein by reference.

 

Item 5.07

Submission of Matters to a Vote of Security Holders.

At the annual meeting of shareholders of the Company held on April 28, 2026, the shareholders voted on the following proposals:

 

   

a proposal to elect the ten nominees for director named below for terms of one year each;

 

   

a proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the current fiscal year;

 

   

a proposal to approve, by non-binding advisory vote, the Company’s executive compensation;

 

   

a proposal to amend the Company’s Amended and Restated By-laws to allow shareholders owning 25% of the Company’s common stock to call a special meeting of shareholders; and

 

   

a shareholder proposal regarding executive stock ownership.

 


The shareholders elected each of the nominees to serve as a director for a term of one year. The final number of votes cast for or against or abstaining and the number of broker non-votes for each nominee are listed below. The proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm, the proposal to approve, by non-binding advisory vote, the Company’s executive compensation, and the proposal to amend the Company’s Amended and Restated By-laws to allow shareholders owning 25% of the Company’s common stock to call a special meeting of shareholders, which required that a majority of the shares of the Company’s common stock outstanding on the record date and entitled to vote be voted in favor of the proposal, were also approved. The final number of votes cast for or against or abstaining from voting on those three proposals and the number of broker non-votes on the executive compensation proposal and the special shareholder meeting proposal are listed below. The shareholder proposal regarding executive stock ownership was not approved. The final number of votes cast for or against or abstaining from voting and the number of broker non-votes on that proposal are listed below.

 


Proposal #1 – To elect the following nominees as our directors for terms of one year each:

 

Name    Votes in
Favor
     Votes
Against
     Abstentions      Broker Non-Votes  

Peter Barrett, PhD

     93,823,710        5,674,907        102,944        4,512,033  

Samuel R. Chapin

     98,274,034        1,217,291        110,236        4,512,033  

Michael A. Klobuchar

     95,054,936        4,512,726        33,899        4,512,033  

Michelle McMurray-Heath, MD, PhD

     99,095,486        474,287        31,788        4,512,033  

Alexis P. Michas

     95,577,856        3,985,098        38,607        4,512,033  

Prahlad R. Singh, PhD

     96,063,825        3,501,311        36,425        4,512,033  

Sophie V. Vandebroek, PhD

     95,054,306        4,517,332        29,923        4,512,033  

Michael Vounatsos

     97,942,266        1,628,346        30,949        4,512,033  

Frank Witney, PhD

     90,741,896        8,834,876        24,789        4,512,033  

Pascale Witz

     92,501,938        7,058,082        41,541        4,512,033  

Proposal #2 – To ratify the selection of Deloitte & Touche LLP as the Company’s independent public accounting firm for the current fiscal year.

 

For   Against   Abstain   Broker Non-Votes
102,992,151   1,036,994   84,449   0

Proposal #3 – To approve, by non-binding advisory vote, the Company’s executive compensation.

 

For   Against   Abstain   Broker Non-Votes
94,377,138   3,770,364   1,454,059   4,512,033

 


Proposal #4 – To amend the Company’s Amended and Restated By-laws to allow shareholders owning 25% of the Company’s common stock to call a special meeting of shareholders.

 

For   Against   Abstain   Broker Non-Votes
99,086,661   440,300   74,600   4,512,033

Proposal #5- Shareholder proposal regarding executive stock ownership.

 

For   Against   Abstain   Broker Non-Votes
22,974,850   76,502,157   124,554   4,512,033

 


Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit No.

  

Description

3.1    Amended and Restated By-laws, redlined for amendments effective as of April 28, 2026
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    REVVITY, INC.
Date: May 1, 2026     By:   /s/ John L. Healy
    John L. Healy
    Vice President and Assistant Secretary
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Revvity Inc (RVTY)

Reference

Frequently asked questions

When did Revvity Inc file this 8-K?
Revvity Inc (RVTY) filed this Current Report (Form 8-K) with the SEC on May 1, 2026. The accession number assigned by EDGAR is 0001193125-26-201401.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Shareholders approved By-law amendment enabling 25% stockholders to call a special meeting. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Revvity Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Revvity Inc has filed under CIK 31791, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer